ALNYLAM PHARMACEUTICALS, INC. (ALNY) Debt Components
- 2025-12-31: Debt Instrument, Interest Rate, Stated Percentagepure 10.00%; Long-term DebtUSD (m).
- 2025-09-30: Debt Instrument, Interest Rate, Stated Percentagepure 10.00%; Long-term DebtUSD (m).
- 2025-06-30: Debt Instrument, Interest Rate, Stated Percentagepure 10.00%; Long-term DebtUSD (m).
- 2025-03-31: Debt Instrument, Interest Rate, Stated Percentagepure 10.00%; Long-term DebtUSD (m).
ALNYLAM PHARMACEUTICALS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Interest Rate, Stated Percentage pure | Long-term Debt USD |
|---|---|---|
| 2025-12-31 | 10.00% | (m) |
| 2025-09-30 | 10.00% | (m) |
| 2025-06-30 | 10.00% | (m) |
| 2025-03-31 | 10.00% | (m) |
| 2024-12-31 | 10.00% | (m) |
| 2024-09-30 | 11.00% | (m) |
| 2024-06-30 | 11.00% | (m) |
| 2024-03-31 | 11.00% | (m) |
| 2023-12-31 | 11.00% | (m) |
| 2023-09-30 | 12.00% | (m) |
| 2023-06-30 | 12.00% | (m) |
| 2023-03-31 | 12.00% | (m) |
| 2022-12-31 | 12.00% | (m) |
| 2022-09-30 | 13.00% | (m) |
| 2022-06-30 | 13.00% | $677.72M |
| 2022-03-31 | 14.00% | $676.71M |
| 2021-12-31 | (m) | $675.70M |
| 2021-09-30 | 15.00% | $433.80M |
| 2021-06-30 | 15.00% | $433.15M |
| 2021-03-31 | 15.00% | $191.59M |
| 2020-12-31 | (m) | $191.28M |
| 2020-08-31 | 14.00% | (m) |
| 2020-08-15 | 15.00% | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |